• Latest Posts

Novo Nordisk Gets Close to Launching the First Oral GLP-1 Drug for Diabetes

Swiss-US Partners Reveal New Candidate for Autoimmune Disease

Fresh Cash for a Device that Can Treat Diabetes and Prevent HIV

Could this be the ‘Beginning of the end’ for Diabetes? Let’s Review.

Swiss-US Implant could make taking pills obsolete in Autoimmune Diseases

Servier to revolutionize Diabetes treatment thanks to Intarcia’s successful Phase III


Review: The Future of Biomarkers in Immuno-Oncology

Why do Servier bets one Billion euros on Revolutionary Diabetes Drugs Delivery Device?